Navigation Links
Almac has Successful MHRA Inspection at its Clinical Services UK Site
Date:10/17/2010

Almac has Successful MHRA Inspection at its Clinical Services UK Site -- CRAIGAVON, Northern Ireland, October 18, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biometrics, Biotechnology, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Corporate Expansion, New Products & Services, European Government Click to view news release full screen  

Almac has Successful MHRA Inspection at its Clinical Services UK Site

 

CRAIGAVON, Northern Ireland, October 18, 2010 /PRNewswire/ -- Almac is once again pleased to announce the successful completion of an inspection of its Clinical Services UK facility located in Craigavon by the Medicines and Healthcare products Regulatory Agency (MHRA).

The routine inspection, which took place over four days, from September 13th - September 16th, was conducted by a MHRA inspector who concluded that the site continues to be compliant with EU Good Manufacturing Practices, with no critical or major failures observed.

Commenting on the inspection, Paul O'Connor (Vice President, Quality), said:

"We are extremely pleased with the outcome of our inspection. These successful results are a positive reflection of all the investment Almac has made over the past few years in our facilities and recruitment of the best employees, ensuring that we are a market leader and continue to deliver a high quality service. Quality is at the core of our ethos - we have three MHRA approved facilities globally, including our additional FDA assessed US facilities in Audubon, Pennsylvania and Durham, North Carolina. The very high standards of quality compliance will continue with our new $120 million North American Headquarters in Souderton - scheduled to open during the autumn."

Notes to Editors

About Almac:

The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors.

The company employs over 2,800 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Almac has officially gained full possession of its new $120m North American Headquarters, which started in July 2008, and employees will relocate during the fall.

For more information on Almac, please visit http://www.almacgroup.com Contact: Aileen Murphy aileen.murphy@almacgroup.com Tel: +44(0)28-3836-2436
'/>"/>

SOURCE Almac Group
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. University of Nevada, Reno, demonstrates successful sludge-to-power research
2. University of Nevada, Reno demonstrates successful sludge-to-power research
3. New method successfully predicted how oil from Deepwater Horizon spill would spread
4. School-based intervention successfully lowers drinking rates in at risk children
5. Scientists successfully use human induced pluripotent stem cells to treat Parkinsons in rodents
6. Pitt researcher says simple polymer-based filter successfully cleans water, recovers oil in Gulf of Mexico tests
7. Polymer-based filter successfully cleans water, recovers oil in Gulf of Mexico test
8. Cell Transplantation reports consistent and successful islet isolations offer diabetes hope
9. Novel protein essential for successful pregnancy
10. Successful launch for ESAs CryoSat-2 ice satellite
11. Successful genome sequencing of pea aphid is a breakthrough for ecology and agricultural research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Feb. 9, 2016 Vigilant Solutions announces today that ... (LPR) to develop a lead in a difficult homicide case. ... data to locate the suspect vehicle. Due to the ongoing ... have been omitted at the agency,s request. ... explains, "Our victim was found deceased at an intersection here ...
(Date:2/3/2016)... GOTHENBURG, Sweden , February 4, 2016 ... Revenues amounted to SEK 1,351.5 M (105.0), up 1,187% compared with fourth ... Operating profit amounted to SEK 517.6 M (loss: 30.0). Earnings ... from operating activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% ...
(Date:2/2/2016)... , Feb. 2, 2016  BioMEMS ... are primarily focused on medical screening and ... point-of-care parameters. Wearable devices that facilitate and ... freedom of movement are being bolstered through ... human biomedical signal acquisition coupled with wireless ...
Breaking Biology News(10 mins):
(Date:2/9/2016)... ... 09, 2016 , ... PharmApprove announced today the ... Organization for Rare Disorders (NORD). Dorman will lead PharmApprove efforts to work with ... the drug regulatory review process. , “Adding Diane Dorman is just the latest ...
(Date:2/9/2016)... Three-Year Initiative Supports Next Generation of Medical Geneticists ... Camp Experiences SHPG ... lives of children born with rare diseases, as well as the ... announcing a new initiative designed to positively affect the lives of ... rare disease care. --> To mark the company,s founding ...
(Date:2/8/2016)... Should antibiotic bone cement products be used ... infection after standard total hip or knee replacement surgery? ... have been fielding a lot lately. "Antibiotic ... --> "Antibiotic Bone Cement: Fighting ... --> While there isn,t a simple answer, ECRI ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... Todorow is the Executive Vice President for Corporate Services and the Chief Financial ... Accounts Payable, Payroll, Billing Operations, Treasury, Managed Care Contracting, Supply Chain, and Investments. ...
Breaking Biology Technology: